A Comparison of The Effects of Clobetasol 0.05% and Photodynamic Therapy Using Aminolevulinic Acid With Red Light in the Treatment of Severe Nail Psoriasis
Journal of Lasers in Medical Sciences,
Vol. 11 No. 1 (2020),
18 January 2020
,
Page 3-7
Abstract
Introduction: The treatment of nail psoriasis is often difficult and unsatisfactory due to therapy resistance. This study aimed to compare the efficacy of clobetasol 0.05% ointment and photodynamic therapy (PDT) using aminolevulinic acid (ALA) and red light in the treatment of severe nail psoriasis.
Methods: This open-trial study included 69 nails of 8 patients with severe nail psoriasis. Thirty-four nails were treated with clobetasol 0.05% ointment and 35 nails were treated with ALA-PDT. ALA-PDT treatment was performed every 3 weeks for 5 cycles; the nails were treated with clobetasol under occlusion every day during the study. All the patients were followed up after 24 weeks. The severity of nail involvement was measured by the Nail Psoriasis Severity Index (NAPSI) scores at the baseline and during the treatment.
Results: There were no significant differences in the NAPSI scores between the treatment groups in the baseline and weeks 3, 6 and 9 (all P > 0.05), although significant differences were found in weeks 12, 15 and 24 (follow-up) (P < 0.001). A significant time-effect improvement was found in all the nail-matrix, nail-bed and total NAPSI scores in both treatment groups (all P < 0.001). The patients did not report intense pain and discomfort during irradiation.
Conclusion: Clobetasol 0.05% ointment seems to be effective in treating nail psoriasis after a treatment period of 15 weeks. However, the efficacy of ALA-PDT at a 24-week follow-up was greater than that of clobetasol.
- Nail psoriasis
- Photodynamic therapy
- Aminolevulinic acid
- Red light
- Clobetasol
How to Cite
References
Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, et al. Psoriasis. Nat Rev Dis Primers. 2016;2:16082. doi: 10.1038/nrdp.2016.82.
Dogra A, Arora AK. Nail Psoriasis: The Journey So Far. Indian J Dermatol. 2014;59(4):319-333. doi: 10.4103/0019-5154.135470.
Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY. Psoriasis of the nail: anatomy, pathology, clinical
presentation, and a review of the literature on therapy. J Am Acad Dermatol. 2007;57(1):1-27. doi: 10.1016/j. jaad.2005.07.073.
Ortonne JP, Baran R, Corvest M, Schmitt C, Voisard JJ, Taieb C. Development and validation of nail psoriasis
quality of life scale (NPQ10). J Eur Acad Dermatol Venereol. 2010;24(1):22-27. doi: 10.1111/j.1468-3083.2009.03344.x.
Haneke E. Nail psoriasis: clinical features, pathogenesis, differential diagnoses, and management. Psoriasis (Auckl).
;7:51-63. doi: 10.2147/PTT.S126281.
Raposo I, Torres T. Nail psoriasis as a predictor of the development of psoriatic arthritis. Actas Dermosifiliogr.
;106(6):452-457. doi: 10.1016/j.ad.2015.02.005.
Lawry M. Biological therapy and nail psoriasis. Dermatol Ther. 2007;20(1):60-67. doi: 10.1111/j.1529-8019.2007.00112.x.
Megna M, Fabbrocini G, Marasca C, Monfrecola G. Photodynamic Therapy and Skin Appendage Disorders: A
Review. Skin Appendage Disord. 2017;2(3-4):166-176. doi: 10.1159/000453273.
Zhang L, Wu Y, Zhang Y, Liu X, Wang B, Wang P, et al. Topical 5-aminolevulinic photodynamic therapy with red light vs intense pulsed light for the treatment of acne vulgaris: A spilit face, randomized, prospective
study. Dermatoendocrinol. 2017;9(1):e1375634. doi: 10.1080/19381980.2017.1375634.
Fernández-Guarino M, Harto A, Sánchez-Ronco M, García-Morales I, Jaén P. Pulsed dye laser vs. photodynamic therapy in the treatment of refractory nail psoriasis: a comparative pilot study. J Eur Acad Dermatol
Venereol. 2009;23(8):891-895. doi: 10.1111/j.1468-3083.2009.03196.x.
Choi YM, Adelzadeh L, Wu JJ. Photodynamic therapy for psoriasis. J Dermatolog Treat. 2015;26(3):202-207. doi:
3109/09546634.2014.927816.
Stringer MR, Collins P, Robinson DJ, Stables GI, Sheehan-Dare RA. The accumulation of protoporphyrin IX in plaque
psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy.
J Invest Dermatol. 1996;107(1):76-81. doi: 10.1111/1523-1747.ep12298282.
Krutmann J, Hönigsmann H, Elmets CA, Bergstresser PR,editors. Dermatological Phototherapy and Photodiagnostic
Methods. Berlin: Springer; 2009.
Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol.
;49(2):206-212. doi: 10.1067/s0190-9622(03)00910-1.
Cannavò SP, Guarneri F, Vaccaro M, Borgia F, Guarneri B. Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebocontrolled study. Dermatology. 2003;206(2):153-156. doi:10.1159/000068469.
Piraccini BM, Starace M. Optimal management of nail disease in patients with psoriasis. Psoriasis (Auckl).
;5:25-33. doi: 10.2147/PTT.S55338.
Rigopoulos D, Ioannides D, Prastitis N, Katsambas A. Nail psoriasis: a combined treatment using calcipotriol cream
and clobetasol propionate cream. Acta Derm Venereol. 2002;82(2):140. doi: 10.1080/00015550252948220.
Wolf R, Tur E, Brenner S. Corticosteroid-induced ‘disappearing digit’. J Am Acad Dermatol. 1990;23(4):755-
doi: 10.1016/s0190-9622(08)81079-1.
Rigopoulos D, Gregoriou S, Katsambas A. Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol
propionate 0.05% cream: a double-blind study. Acta Derm Venereol. 2007;87(2):167-8. doi: 10.2340/00015555-0195.
Nakamura RC, Abreu L, Duque-Estrada B, Tamler C, Leverone AP. Comparison of nail lacquer clobetasol efficacy at 0.05%, 1% and 8% in nail psoriasis treatment: prospective, controlled and randomized pilot study. An
Bras Dermatol. 2012;87(2):203-211. doi: 10.1590/s0365- 05962012000200003.
Barrea L, Nappi F, Di Somma C, Savanelli MC, Falco A, Balato A, et al. Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist. Int J Environ Res Public Health. 2016;13(7):743. doi: 10.3390/ijerph13070743.
Johnson JA, Ma C, Kanada KN, Armstrong AW. Diet and nutrition in psoriasis: analysis of the National Health and Nutrition Examination Survey (NHANES) in the United States. J Eur Acad Dermatol Venereol. 2014;28(3):327-32. doi: 10.1111/jdv.12105.
Naldi L. Risk Factors for Psoriasis. Curr Derm Rep. 2013;2(1):58-65. doi: 10.1007/s13671-012-0034-6.
Abrouk M, Lee K, Brodsky M, Nakamura M, Singh R, Zhu TH, et al. Ethnicity affects the presenting severity of psoriasis. J Am Acad Dermatol. 2017;77(1):180-182. doi: 10.1016/j.jaad.2017.02.042.
Kim JY, Kang HY, Lee ES, Kim YC. Topical
-aminolaevulinic acid photodynamic therapy for intractable palmoplantar psoriasis. J Dermatol. 2007;34(1):37-40. doi: 10.1111/j.1346-8138.2007.00213.x.
Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159(6):1245-66. doi: 10.1111/j.1365- 2133.2008.08882.x.
Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, et al. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol. 2007;34(1):123-9.
- Abstract Viewed: 527 times
- PDF Downloaded: 438 times